@ShahidNShah
Podcast on Decision Support for Selecting Digital Health Tools
Selecting digital health tools is tricky. There are thousands of innovators vying for your attention and dollars. They all promise to help you “get back to doing what you do best, caring for patients” (side note: I think that one has run its course – let’s move on marketers). But how can you be sure they’re selling something that will work for you?
That’s where Medigy comes in. It’s a decision support tool for selecting digital health tools. Our very own Shahid Shah is behind this one, and he’s created a platform that enables quantitative analysis of digital health tools to help you make objective purchasing decisions based on clearly defined objectives and key results, or OKRs. That’s fancy talk for: What does it do? Who is it for? How is it objectively measures and validated?
Shahid describes it as a kind of eternal digital health innovation challenge where innovators share they’re latest and greatest so that end-users and industry influencers can pick the winners. Medigy is a peer network that puts these evaluations in a structured format and maps it to existing classification systems of industry analysts like KLAS and Gartner. The idea is not to compete with those analysts, but to add another valuable input into the buying process that pairs with and complements their reports. What you end up with is a Yelp-like review page full of structured, quantifiable reviews with links to more information.
Medigy primarily serves buyers and influencers. Buyers get access to rich content about the digital health products they’re after. Influencers get a new place to build and engage with a community around their areas of expertise. However, the value to vendors and innovators (the supply-side) is pretty apparent. It’s a place for your product to be evaluated in a consistent and purposeful way. And it can be a great way to engage with your customers for feedback and requests.
Continue reading at thehcbiz.com
Make faster decisions with community advice
- Reimbursement, data interoperability and risk aversion are holding back digital health innovation
- The Top 100 Companies In Digital Health Addressing Real-World Needs
- The potential of healthcare tech – human-centric AI, meaningful applications and the future
- 5 things we found in the FDA’s hidden device database
- Beyond the hype: Here’s how oncologists view the future impact of AI
Next Article
-
Reimbursement, data interoperability and risk aversion are holding back digital health innovation
Recent data from VC firm Rock Health on digital health funding numbers point to a declining trend of investments in early-stage funding, especially Series A and B. Of the 64 deals financed in Q1 2019, …
Posted Jun 30, 2019